Two cases of hepatocellular carcinoma with erythrocytosis

Erythrocytosis associated with hepatocellular carcinoma.

I N A PREVIOUS STUDY, it was shown that erythrocytosis was present in 11.7 per cent of southern Chinese patients with hepatocellular carcinoma but that the mechanism of production remained obscure.’ Plasma erythropoiesis-stimulating factor ( ESF ), assayed on the fasted rat, was not increased in four subjects studied. Subsequent reports of the existence of erythrocytosis in hepatocellular carci...

Hepatocellular Carcinoma in Sheep

A possible mechanism for the erythrocytosis associated with hepatocellular carcinoma in man.

these pathological states, elevated levels of erythropoietin (ESF) have been detected in the serum, plasma, or urine, and in the affected tissues or encvsted fluid. Such observations have led to the speculation that increased production of the ESF by the tumor tissue may be responsible for the development of the accompanying erythrocytosis. In attempting to determine the mechanism underlying th...

Hepatocellular carcinoma: analysis of 76 cases.

Hepatocellular carcinoma is one of the most common malignancies world wide. We present data on 76 patients admitted to the Shaikh Zayed Hospital. Mean age was 52.2 +/- 11.3 years. Eighty six percent were males and 14% females. Eighty-six percent patients had underlying cirrhosis documented on ultrasound examination. Seventy-five percent were positive for anti HCV, 10% for HBsAg positive, 10% fo...

Hepatocellular Carcinoma with Prominent Intracytoplasmic Inclusions: A Report of Two Cases

Hepatocellular carcinoma (HCC) is the commonest primary malignant neoplasm of the liver in most countries with a notoriously poor prognosis. Variation in global incidence is well-recognized and the occurrence of HCC is linked to several established environmental, dietary, and lifestyle factors. HCC demonstrates morphological heterogeneity both within the same tumor and from patient to patient. ...